Total Payments
$99,422
2024 Payments
$51,287
Companies
17
Transactions
202
Medicare Patients
2,672
Medicare Billing
$315,130
Payment Breakdown by Category
Other$74,341 (74.8%)
Travel$13,824 (13.9%)
Food & Beverage$5,391 (5.4%)
Consulting$4,950 (5.0%)
Research$916.00 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $74,341 | 36 | 74.8% |
| Travel and Lodging | $13,824 | 78 | 13.9% |
| Food and Beverage | $5,391 | 85 | 5.4% |
| Consulting Fee | $4,950 | 1 | 5.0% |
| Unspecified | $916.00 | 2 | 0.9% |
Payments by Type
General
$98,506
200 transactions
Research
$916.00
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $82,846 | 139 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $14,373 | 32 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $916.00 | 2 | $0 (2021) |
| Amgen Inc. | $274.00 | 3 | $0 (2024) |
| Novo Nordisk Inc | $156.15 | 3 | $0 (2023) |
| Horizon Therapeutics plc | $148.83 | 1 | $0 (2023) |
| Lilly USA, LLC | $124.86 | 7 | $0 (2024) |
| Dexcom, Inc. | $123.17 | 3 | $0 (2024) |
| Antares Pharma, Inc. | $119.32 | 2 | $0 (2023) |
| Corcept Therapeutics | $87.40 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,287 | 109 | Alexion Pharmaceuticals, Inc. ($46,410) |
| 2023 | $46,886 | 80 | Alexion Pharmaceuticals, Inc. ($36,436) |
| 2022 | $283.49 | 8 | Corcept Therapeutics ($87.40) |
| 2021 | $965.34 | 5 | Neurocrine Biosciences, Inc. ($916.00) |
All Payment Transactions
202 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $112.65 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | In-kind items and services | $17.99 | General |
| Category: Rare Disease | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | In-kind items and services | $17.99 | General |
| Category: Rare Disease | ||||||
| 10/30/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $134.33 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/04/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $117.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/18/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $139.10 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/02/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $154.88 | General |
| Category: Bone Health | ||||||
| 05/16/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| 05/16/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.79 | General |
| 05/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: Rare Disease | ||||||
| 05/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | In-kind items and services | $534.20 | General |
| Category: Rare Disease | ||||||
| 05/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | In-kind items and services | $306.06 | General |
| Category: Rare Disease | ||||||
| 05/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | Cash or cash equivalent | $109.42 | General |
| Category: Rare Disease | ||||||
| 05/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | Cash or cash equivalent | $81.71 | General |
| Category: Rare Disease | ||||||
| 05/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | Cash or cash equivalent | $30.68 | General |
| Category: Rare Disease | ||||||
| 05/01/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | Cash or cash equivalent | $110.50 | General |
| Category: Rare Disease | ||||||
| 05/01/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | Cash or cash equivalent | $83.34 | General |
| Category: Rare Disease | ||||||
| 05/01/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | Cash or cash equivalent | $74.06 | General |
| Category: Rare Disease | ||||||
| 05/01/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | Cash or cash equivalent | $16.10 | General |
| Category: Rare Disease | ||||||
| 04/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $99.70 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/19/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $60.23 | General |
| 04/19/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.45 | General |
| 04/18/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| INTEGRATED SOLUTIONS TO DEMONSTRATE THE VALUE OF NBI-74788 IN CONGENTIAL ADRENAL HYPERPLASIA | Neurocrine Biosciences, Inc. | $916.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 555 | 5,384 | $338,142 | $131,573 |
| 2022 | 16 | 1,178 | 3,689 | $419,795 | $118,217 |
| 2021 | 11 | 651 | 721 | $176,077 | $44,721 |
| 2020 | 10 | 288 | 330 | $67,536 | $20,618 |
Total Patients
2,672
Total Services
10,124
Medicare Billing
$315,130
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 48 | 4,620 | $205,472 | $84,627 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 78 | 104 | $32,760 | $14,655 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 128 | $30,720 | $13,061 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $18,200 | $6,025 | 33.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 63 | $11,025 | $4,439 | 40.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $11,431 | $4,144 | 36.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 50 | 90 | $7,560 | $1,077 | 14.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 17 | 17 | $3,570 | $932.40 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $2,380 | $778.59 | 32.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 71 | 71 | $5,821 | $744.08 | 12.8% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 17 | 85 | $6,731 | $442.21 | 6.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 30 | 43 | $1,806 | $409.36 | 22.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 45 | 74 | $666.00 | $237.54 | 35.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 28 | 2,340 | $94,627 | $40,001 | 42.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 665 | 666 | $202,584 | $30,536 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 134 | $32,160 | $13,768 | 42.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 68 | 89 | $28,035 | $13,061 | 46.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $13,300 | $4,868 | 36.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 56 | $9,800 | $3,591 | 36.6% |
| 77081 | Dxa bone density measurement of forearm, finger, hand, or foot | Office | 2022 | 73 | 73 | $8,030 | $2,808 | 35.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $6,461 | $2,658 | 41.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $5,922 | $2,192 | 37.0% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2022 | 22 | 22 | $3,124 | $1,397 | 44.7% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2022 | 11 | 22 | $2,926 | $1,091 | 37.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 11 | 11 | $2,310 | $738.91 | 32.0% |
About Diala El-Maouche, MD, MS
Diala El-Maouche, MD, MS is a Internal Medicine healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1487817821.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Diala El-Maouche, MD, MS has received a total of $99,422 in payments from pharmaceutical and medical device companies, with $51,287 received in 2024. These payments were reported across 202 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($74,341).
As a Medicare-enrolled provider, El-Maouche has provided services to 2,672 Medicare beneficiaries, totaling 10,124 services with total Medicare billing of $315,130. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Washington, DC
- Active Since 07/07/2008
- Last Updated 12/19/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1487817821
Products in Payments
- STRENSIQ (Biological) $23,160
- TZIELD (Biological) $11,126
- EVENITY (Biological) $172.24
- TEPEZZA (Drug) $148.83
- Dexcom G6 Transmitter (Medical Supply) $123.17
- Wegovy (Drug) $122.51
- TLANDO (Drug) $101.91
- Prolia (Biological) $101.76
- Korlym (Drug) $87.40
- Omnipod (Device) $84.22
- MOUNJARO (Drug) $69.29
- SOLIQUA 100/33 (Biological) $36.25
- JARDIANCE (Drug) $35.25
- MINIMED 770G (Device) $27.87
- TOUJEO (Biological) $27.67
- FREESTYLE LIBRE 2 (Device) $24.82
- FREESTYLE LIBRE 3 (Device) $23.25
- XYOSTED (Drug) $22.20
- SIGNIFOR LAR (Drug) $21.01
- TRULICITY (Drug) $20.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Washington
Lawrence Dubuske, M.d, M.D
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Kavita Patel, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Andrea Singer
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Theo Hodge, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Ashte Collins, M.d, M.D
Internal Medicine — Payments: $837,513
Internal Medicine $837,513
Manish Shah, Md, MD
Internal Medicine — Payments: $456,731
Internal Medicine $456,731